By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PerkinElmer, Inc. 

940 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-663-6900 Fax:

PerkinElmer, Inc. is a global technology leader providing scientific instruments, consumables and services to the pharmaceutical, biomedical, environmental testing and general industrial markets that require innovation, precision and reliability. We design, manufacture, market and service products and systems within three business units: Life and Analytical Sciences, Optoelectronics and Fluid Sciences.

Facts about PerkinElmer

  • 2003 Revenue $1.535 Billion
  • Operating in 125 countries
  • 10,000 employees
  • Member S&P 500 Index

    PerkinElmer Life and Analytical Sciences

    549 Albany Street
    Boston, MA 02118, USA
    Telephone General Information 617-482-9595 or Customer Care 800-762-4000 (USA only)

    A $1 billion market leader, PerkinElmer LAS serves a number of growing industries and markets including the academic research, biotechnology, clinical screening, pharmaceutical, environmental, forensic, petrochemical and semiconductor segments. Our instruments, reagents, consumables and service offerings help our customers solve complex analytical problems encountered in drug discovery and genetic screening laboratories. Our instruments and related software applications measure a range of substances from biomolecular matter to organic and inorganic materials. Our total application-driven laboratory solutions help our customers speed drug discovery, enhance research productivity, meet strict regulatory requirements, improve time-to-market, and increase manufacturing efficiencies.

    Last Updated: 12-14-04

    Key Statistics

    Ownership: Public

    Web Site: PerkinElmer
    Symbol: PKI

  • Industry

    Company News
    PerkinElmer (PKI) Announces Future Retirement Of Andy Wilson, Chief Financial Officer 9/18/2017 7:37:56 AM
    PerkinElmer (PKI) And In-Depth Genomics Team Up For Whole Genome Sequencing Diagnostic Program For Rare Diseases 9/14/2017 8:06:20 AM
    PerkinElmer (PKI) Launches Qsight 210 MD System For Clinical Laboratories 9/8/2017 10:59:39 AM
    PerkinElmer (PKI) Extends Clinical Whole Genome Sequencing Services 9/7/2017 8:21:57 AM
    PerkinElmer (PKI) Announces Financial Results For The Second Quarter Of 2017 8/4/2017 7:42:02 AM
    PerkinElmer (PKI) Launches Clinical Whole Genome Sequencing Services 8/4/2017 6:54:51 AM
    PerkinElmer (PKI) Board Declares Quarterly Dividend 7/25/2017 8:23:03 AM
    PerkinElmer (PKI) To Hold Earnings Call On Thursday, August 3, 2017 7/11/2017 7:24:39 AM
    PerkinElmer (PKI) Release: Groundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspirin Therapy Reduces Rate Of Pre-Term Preeclampsia 6/28/2017 11:07:45 AM
    PerkinElmer (PKI) Slams Down $1.3 Billion for Germany's EUROIMMUN 6/19/2017 5:44:14 AM